Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Mod GRF 1-29 & GHRP-2 Research on Muscle and Body Composition Growth hormonerelated peptides have been studied for their potential roles in supporting skeletal muscle activity
Current availability status Semaglutide: FDA approved as Wegovy (weight loss) and Ozempic (diabetes) Prescription required Widely available through pharmacies Also available as research chemical Well-established sourcing Cagrilintide: NOT FDA approved (as of 2024) In Phase 3 clinical trials Not commercially available via prescription Only available as research chemical Limited vendors carry it CagriSema (combined product): Novo Nordisk's brand name In Phase 3 trials Not yet approved Anticipated FDA review 2025-2026 Will require prescription when approved Research chemical sourcing For semaglutide: Many established research chemical vendors Quality varies significantly Third-party testing essential Typical cost: $150-300 per 5mg vial Lasts 2-4 weeks at 2.4mg dose For cagrilintide: Very limited vendors currently Newer peptide, less available Quality even more variable Higher cost due to scarcity: $200-400 per 2.4mg vial Many vendors don't carry it yet Quality verification: Certificate of Analysis (COA) required Purity should be 95% Recent testing (within 6 months) Batch number matching Established vendor reputation Red flags: No testing documentation Suspiciously cheap prices New, unknown vendors Poor communication Inconsistent product quality reports See our best peptide vendors , are peptides legal , and research vs pharmaceutical peptides
Henry Legere founded the second-largest clinical allergy practice and research center, and his team is known for its medical technology innovation and advanced protocols
Frequently asked questions 1
HbA1c improved, with some participants in the higher dose arms achieving values consistent with prediabetes resolution
Glutathione-S-transferase-pi expression regulates sensitivity to [PMID: 11604559] Laboratory literature summary: Glutathione-S-transferase-pi expression regulates sensitivity to glutathione-doxorubicin conjugate
